Company News
- [News Brief] Samsung Biologics attends CITIC CLSA Investors’ Forum
- [News Brief] Samsung Biologics showcases CDO capabilities at BPI 2023
- [Media Focus] Accelerating Biologics Manufacturing: Strategies for Efficient Production Timelines
- [Press Releases] Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture antibody cancer drug substance